LRP6 Antibodies

Santa Cruz Biotechnology delivers a wide array of LRP6 monoclonal antibodies for research focused on understanding LRP6 protein's role in various biological processes. LRP6 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LRP6, or Low-Density Lipoprotein Receptor-Related Protein 6, functions as a key component of the Wnt signaling pathway, playing essential roles in cell proliferation, differentiation, and embryonic development. Research has shown that LRP6 dysfunction contributes to various diseases, including cancer and metabolic disorders, highlighting its significance as a therapeutic target. Investigating LRP6 function through specific molecular tools enables researchers to better understand cellular signaling mechanisms. Advanced research techniques using LRP6 monoclonal antibodies help reveal new insights about cellular pathways and disease mechanisms. Exploring LRP6's role in development and disease progression provides opportunities for therapeutic innovations. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cellular processes and disease mechanisms.